Specialised Therapeutics Australia (STA) welcomes the opportunity to provide comments on the introduction of new measures to improve TGA transparency. STA was co-founded in 2008, with a commitment to commercialising specialist therapies and technologies that meet the unmet medical needs of all patients in its regions. Underpinning this endeavour is a foundation of innovation, which must be protected by regulatory transparency.
By Carlo Montagner, CEO Specialised Therapeutics Australia Dear PBS Improvements Section, My name is Carlo Montagner and I am the Chief Executive Officer and co-founder of Australia’s largest independent pharmaceutical company, Specialised Therapeutics Australia (STA). We are a wholly family-owned Australian company, supplying specialist therapies and technologies to patients throughout Australia, as well as in